Specific active immunotherapy with the vaccine preparation NGcGM3/VSSP in the treatment of patients with metastatic cutaneous melanoma
Latest Information Update: 14 Oct 2020
At a glance
- Drugs N-glycolyl GM3 vaccine (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 17 Jan 2017 New trial record